Venus Medtech (Hangzhou) Class H Accounts Payable

As of the most recent data (June 2026), VMTHF shows a accounts payable of $16M. That compares with $22M in the prior-year period — down 29.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VMTHF's accounts payable is now $16M (was $22M) — a 29.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Venus Medtech (Hangzhou) Class H is outperforming or lagging.

Tracking VMTHF's accounts payable over time shows whether Venus Medtech (Hangzhou) Class H is scaling, shrinking, or reshaping that part of the business. The current reading is $16M That compares with $22M in the prior-year period — down 29.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Venus Medtech (Hangzhou) Class H's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $16M) with ownership activity and broader fundamentals.